Dr. Hamdan Al-Shahrani is a physician-scientist specializing in Medical Genetics and Clinical Biochemical Genetics (CCMG). He is currently a Consultant Genetics in PSMMC, Riyadh, Sa and clinical investigator at Mount Sinai Hospital (New York) working with the CDG team. His research focuses on the clinical and molecular characterization of rare metabolic and genetic disorders, particularly CDG. His interests include molecular genetics, translational genomics, and bioinformatics approaches to rare disease diagnostics. Dr. Al-Shahrani aims to bridge clinical medicine and genomic science to improve diagnosis and develop translational strategies for patients with rare metabolic disorders.